Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

about

Heterologous Vaccination and Checkpoint Blockade Synergize To Induce Antileukemia Immunity.Evolving Approaches in the Identification of Allograft-reactive T and B Cells in Mice and Humans.

P2860

Q36923835-8CCC5C3B-C0C9-447D-B6D7-5412D9B64663 Q39366464-16AE39E7-3F63-4569-A76B-DEC35E7691D1

P2860

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

Item

http://www.wikidata.org/entity/Q36119409

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@ast

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@en

type

Item

label

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@ast

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@en

prefLabel

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@ast

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@en

P1476

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

@en

P2093

Katherine E Berquam-Vrieze

http://www.w3.org/2001/XMLSchema#string

Kristen E Pauken

http://www.w3.org/2001/XMLSchema#string

Richard T Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia

Nivolumab plus ipilimumab in advanced melanoma.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity

Signatures of mutational processes in human cancer

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Chimeric antigen receptor T cells for sustained remissions in leukemia

T cell receptor antagonist peptides induce positive selection

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

Genetic basis for clinical response to CTLA-4 blockade in melanoma

P304

4028-4037

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1501291

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P50

Marc K. Jenkins

Michael A Farrar

Luke S Manlove

P577

2015-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26378075

http://www.w3.org/2001/XMLSchema#string

P932

4592825

http://www.w3.org/2001/XMLSchema#string

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

about

P2860

P2860

Adaptive Immunity to Leukemia Is Inhibited by Cross-Reactive Induced Regulatory T Cells

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932